{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:59:48Z","timestamp":1785077988016,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108312","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:14:49Z","timestamp":1781936089000},"page":"108312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting RNA quality-control defects in tauopathies: Pharmacodynamic biomarkers and therapeutic development"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-3711","authenticated-orcid":false,"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-418X","authenticated-orcid":false,"given":"Aifang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108312_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108312_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2026.108312_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2026.108312_bib4","doi-asserted-by":"crossref","first-page":"8129","DOI":"10.1002\/alz.14250","article-title":"A framework for translating tauopathy therapeutics: Drug discovery to clinical trials","volume":"20","author":"Feldman","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2026.108312_bib5","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1016\/j.cell.2025.11.033","article-title":"The evolving landscape of Alzheimer's disease therapy: From Abeta to tau","volume":"188","author":"Courade","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108312_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108312_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105322","article-title":"Insights into the use of biomarkers in clinical trials in Alzheimer's disease","volume":"108","author":"Pascoal","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2026.108312_bib8","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/awad032","article-title":"Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change","volume":"146","author":"McMillan","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2026.108312_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/alz.12653","article-title":"Tau-induced deficits in nonsense-mediated mRNA decay contribute to neurodegeneration","volume":"19","author":"Zuniga","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2026.108312_bib10","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1038\/s41380-023-02237-2","article-title":"Long non-coding RNA SNHG8 drives stress granule formation in tauopathies","volume":"28","author":"Bhagat","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2026.108312_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s44318-024-00352-6","article-title":"RNA dysregulation in neurodegenerative diseases","volume":"44","author":"Li","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108312_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13059-021-02439-3","article-title":"Nanopore sequencing reveals endogenous NMD-targeted isoforms in human cells","volume":"22","author":"Karousis","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.phrs.2026.108312_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.tins.2023.07.001","article-title":"Nonsense-mediated mRNA decay in neuronal physiology and neurodegeneration","volume":"46","author":"Petric Howe","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2026.108312_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108312_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14245","article-title":"Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease","volume":"23","author":"Zuniga","year":"2024","journal-title":"Aging Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s12276-025-01623-w","article-title":"Quality control and signaling pathways at stalled ribosomes","volume":"58","author":"Chang","year":"2026","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2026.108312_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1261\/rna.080272.124","article-title":"New reporters for monitoring cellular NMD","volume":"31","author":"Alalam","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.phrs.2026.108312_bib18","article-title":"Biomarkers for Alzheimer's Disease: Context of Use, Qualification, and Roadmap for Clinical Implementation","volume":"58","author":"Cummings","year":"2022","journal-title":"Med. (Kaunas. )"},{"key":"10.1016\/j.phrs.2026.108312_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108312_bib20","article-title":"Altered localization of nucleoporin 98 in primary tauopathies","volume":"5","author":"Dickson","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.phrs.2026.108312_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12847","article-title":"Tau-induced nuclear envelope invagination causes a toxic accumulation of mRNA in Drosophila","volume":"18","author":"Cornelison","year":"2019","journal-title":"Aging Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib22","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.molcel.2024.08.028","article-title":"Understanding nuclear mRNA export: Survival under stress","volume":"84","author":"Seidler","year":"2024","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1755","article-title":"Mechanisms of RNA export and nuclear retention","volume":"14","author":"Khan","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.phrs.2026.108312_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad097","article-title":"Nucleoporin 98 mislocalization is a common feature in primary tauopathies","volume":"5","author":"Nag","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.phrs.2026.108312_bib25","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/alz.13535","article-title":"Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers","volume":"20","author":"Sun","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.phrs.2026.108312_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104953","article-title":"Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3","volume":"100","author":"Ruiz-Gabarre","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2026.108312_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115867","article-title":"Mislocalization of nucleic acids is a convergent and targetable mechanism in Alzheimer's disease and frontotemporal dementia","volume":"44","author":"Hung","year":"2025","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108312_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.neuron.2021.03.026","article-title":"Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components","volume":"109","author":"Lester","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108312_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014188118","article-title":"TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau","volume":"118","author":"Ash","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2026.108312_bib30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-981-32-9358-8_26","article-title":"The Pathophysiology of Tau and Stress Granules in Disease","volume":"1184","author":"Cruz","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2026.108312_bib31","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.molcel.2022.05.014","article-title":"Stressful steps: Progress and challenges in understanding stress-induced mRNA condensation and accumulation in stress granules","volume":"82","author":"Glauninger","year":"2022","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib32","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1021\/acs.chemrev.2c00608","article-title":"A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules","volume":"123","author":"Millar","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.phrs.2026.108312_bib33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1101\/gad.350518.123","article-title":"RNA granules: functional compartments or incidental condensates?","volume":"37","author":"Putnam","year":"2023","journal-title":"Genes. Dev."},{"key":"10.1016\/j.phrs.2026.108312_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105342","article-title":"Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease","volume":"157","author":"Yu","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2026.108312_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-017-0022-z","article-title":"Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo","volume":"21","author":"Apicco","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2026.108312_bib36","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18413","article-title":"Distinct stages in stress granule assembly and disassembly","volume":"5","author":"Wheeler","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.phrs.2026.108312_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-018-1937-5","article-title":"TIA1 regulates the generation and response to toxic tau oligomers","volume":"137","author":"Jiang","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2026.108312_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-018-0574-5","article-title":"RNA binding proteins co-localize with small tau inclusions in tauopathy","volume":"6","author":"Maziuk","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.phrs.2026.108312_bib39","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1523\/JNEUROSCI.1592-12.2012","article-title":"Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies","volume":"32","author":"Vanderweyde","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2026.108312_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1242925","article-title":"Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders","volume":"16","author":"Naskar","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2026.108312_bib41","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1093\/nar\/gkae655","article-title":"Stress granule formation helps to mitigate neurodegeneration","volume":"52","author":"Glineburg","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2026.108312_bib42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cell.2020.03.049","article-title":"RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation","volume":"181","author":"Guillen-Boixet","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108312_bib43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.molcel.2016.07.021","article-title":"A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and Dynamism","volume":"63","author":"Ganassi","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib44","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.cell.2013.05.037","article-title":"Eukaryotic stress granules are cleared by autophagy and Cdc48\/VCP function","volume":"153","author":"Buchan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2026.108312_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.molcel.2019.03.027","article-title":"ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP\/p97","volume":"74","author":"Wang","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.phrs.2026.108312_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-019-1551-2","article-title":"DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome","volume":"573","author":"Samir","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108312_bib47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1261\/rna.080409.125","article-title":"Dissecting the stress granule RNA world: dynamics, strategies, and data","volume":"31","author":"Biancon","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.phrs.2026.108312_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00401-024-02823-w","article-title":"Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy","volume":"148","author":"Whitney","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2026.108312_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102503","article-title":"Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes","volume":"36","author":"Iwata-Endo","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2026.108312_bib50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.omtn.2022.07.027","article-title":"Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies","volume":"29","author":"Easton","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.phrs.2026.108312_bib51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.abq5622","article-title":"Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies","volume":"379","author":"Baughn","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108312_bib52","article-title":"Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOs","author":"Keuss","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.phrs.2026.108312_bib53","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fneur.2020.01056","article-title":"Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases","volume":"11","author":"Diez","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.phrs.2026.108312_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","article-title":"Modulating biomolecular condensates: a novel approach to drug discovery","volume":"21","author":"Mitrea","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.phrs.2026.108312_bib55","article-title":"MAPT Splicing Modulators as a Therapeutic Strategy for Tauopathies","author":"Silva","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.phrs.2026.108312_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","article-title":"Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials","volume":"5","author":"Ossenkoppele","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.phrs.2026.108312_bib57","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","article-title":"Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's disease","volume":"31","author":"Islam","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108312_bib58","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.neuron.2023.05.017","article-title":"Blood-based biomarkers for Alzheimer's disease: current state and future use in a transformed global healthcare landscape","volume":"111","author":"Hampel","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108312_bib59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41573-022-00633-x","article-title":"The evolving role of investigative toxicology in the pharmaceutical industry","volume":"22","author":"Pognan","year":"2023","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.phrs.2026.108312_bib60","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.tips.2024.09.003","article-title":"Phenotypic approaches for CNS drugs","volume":"45","author":"Sharma","year":"2024","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:00:34Z","timestamp":1785074434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"alternative-id":["S1043661826002276"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108312","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting RNA quality-control defects in tauopathies: Pharmacodynamic biomarkers and therapeutic development","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108312"}}